Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

First there was CE marking...now ISO (International Standards Organisation) 13485:

This article was originally published in Clinica

Executive Summary

Concern over a lack of knowledge among purchasers about the significance of the international standard ISO 13485 quality system (QS) standard for medical devices had prompted a group of European medical device industry associations to issue a joint flyer explaining its value. ISO 13485 is based on the generic international system standard, ISO 9001, but is clearly less well publicised. The European associations that represent device manufacturers, COCIR (radiological and electromedical), EDMA (diagnostics), EUROMCONTACT (contact lenses), EUROM VI (mechanical and optical) and FIDE (dental), have joined together in this initiative which they hope will demystify this particular QS standard and explain its significance to devices sector.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT061570

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel